Resident of the Year
Launched in 2017, SHPA’s Foundation Residencies are a key part of Australia’s first structured, formalised, supported and accredited national pharmacy residency program.
Now in its fourth year, the SHPA Resident of the Year (ROTY) Award highlights excellence in practice by a Foundation Resident undertaking the SHPA Foundation Residency Program. The Award specifically focuses on improvement and professional development of a Resident as they have progressed through the term of their SHPA Foundation Residency.
The 2022 ROTY award is open to Foundation Residents who:
- are SHPA members
- are in the second year of the Residency, or
- completed their Foundation Residency between July 2021 and June 2022.
Each Resident will deliver a 5-minute lightning talk with up to 5 slides on one of the following topics:
- their research project or audit undertaken during their Residency
- a case presentation
- a significant learning experience encountered during their Residency
Entries open: Monday 13 June 2022
Entries close: Friday 22 July 2022
Heats: late August 2022
Finalists announced: September 2022
The 2022 ROTY finals will take place at MM2022 being held in Brisbane from 1-3 December 2022
Read more about the previous SHPA Resident of the Year winners
Clinical Pharmacist, Austin Health, Melbourne
Presentation: Hospital outreach medication review to reduce opioid use following surgery.
'Throughout my residency I have had a number of opportunities to work in variety of different areas within the pharmacy department and developed a range of skills during a very difficult time to work in healthcare.
One such experience that stand outs for me was having the opportunity to trial managing a ward remotely during the first wave of COVID-19. This then presented the opportunity to publish an editorial (GRIT 2020-21 Summer Edition) discussing my opinions and experiences providing a clinical pharmacy service remotely.
I also have had the opportunity to work within the Emergency Department, which was a fantastic experience to work in a high-paced, critical care environment during a pandemic. I learned a great deal about working as a clinical pharmacist in this area and this has certainly become an area of interest which I hope to pursue in the future.'
Medication Safety Pharmacist/Post-Resident Pharmacist, Royal Brisbane and Women's Hospital, Brisbane
Presentation: The time is now: ensuring timely and appropriate medications for patients with Parkinson's disease.
'I thoroughly enjoyed being able to rotate through the Neurology/Stroke ward during my time with the Medical team. The highly experienced multidisciplinary team was brilliant. They included me on ward rounds and helped me to learn so much during this foundation period. I think Neurology represents an area of relatively untapped potential for pharmacists. It was powerful to see how much could be achieved with the right medicines in patients with conditions like epilepsy and Parkinson’s disease.'
Renal Pharmacist, Austin Health, Melbourne
Presentation: Opioid use following total knee and hip arthroplasty – not always a case of oversupply.
Jacinta said, ‘I applied for a residency position at the end of my internship, and at the time the key things that appealed to me was having an experienced pharmacist as a mentor for each rotation and looking into the ‘why’ behind therapeutic recommendations. Looking back now, the residency program at the Austin definitely delivered on both aspects.’